Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • COVID-19 Pandemic to Heighten Market Prospects for Drug Delivery Systems: Market Set to Register Strong 7% Growth, Concludes Fact.MR

    May 11, 2020, 09:56 AM by Michael Croft
    DUBLIN 2, IRELAND - May 11, 2020 - The ongoing COVID-19 pandemic is set to leverage the global drug delivery systems market, expanding at a CAGR of 7
    Full story
  • Agendia Co-Founder and Chief Scientific Officer René Bernards, PhD Elected to the National Academy of Sciences

    May 11, 2020, 09:44 AM by Michael Croft
    NEW YORK, NY, UNITED STATES - May 8, 2020 -
    • Development of MammaPrint®,first FDA-cleared molecular diagnostic test for personalized treatment of breast cancer, considered a landmark achievement in breast cancer testing and treatment
     Irvine, California and Amsterdam, Netherlands, May 7, 2020 - Agendia, Inc
    Full story
  • Gene Therapy Company Dyno Therapeutics Pairs Biology With AI For Therapeutic Gains

    May 11, 2020, 08:05 AM by Michael Croft

    Bio-IT World | Dyno Therapeutics emerged from stealth mode today and announced partnerships with Novartis and Sarepta Therapeutics to develop gene therapies for eye disease and neuromuscular and cardiovascular disease.

    Full story
  • Find the One-stop Bispecific Antibody Services and Products at Creative Biolabs

    May 11, 2020, 04:24 AM by Michael Croft
    SHIRLEY, NY, UNITED STATES - May 11, 2020 - Bispecific antibody (BsAb) is a technology that has just been commercialized in the past ten years. However, its commercial prospect has already shown a bright outlook as BsAb has been considered a prospective drug for tumor and cancer treatment and a large number of projects in its research and development are underway
    Full story
  • Spring Bank Pharmaceuticals Reports First Quarter 2020 Financial and Operational Results

    May 8, 2020, 14:25 PM by Michael Croft
    HOPKINTON, MA, UNITED STATES - May 7, 2020 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of certain cancers and inflammatory diseases, today announced its financial results for the first quarter ended March 31, 2020 and provided an update on recent corporate and clinical development highlights
    Full story
  • AI Predicts New COVID-19 Drugs, New Commercial COVID-19 Command Center

    May 8, 2020, 10:35 AM by Michael Croft
    Bio-IT World   New research on COVID-19 treatments and vaccines from worldwide researchers at Northwestern University, Erasmus MC University Medical Center, the Russian Academy of Sciences, the University of Southern California and more. Saama Technologies and iNDX.Ai and launched the COVID-19 Command Center, and AI and supercomputing technologies flag new drugs. We round up the week’s research and industry news for COVID-19.
    Full story
  • AI VIVO seeks collaboration partners to progress top-ranked COVID-19 therapeutic candidates

    May 7, 2020, 11:02 AM by Michael Croft
    CAMBRIDGE, UK - May 7, 2020 -
    • 41 of the candidate drugs from AI VIVO's top-ranked list for COVID-19 are now in clinical trials for COVID-19 by multiple groups globally
    • Demonstrates the ability of AI VIVO's unique phenotypic drug discovery methodology to identify and rank therapeutic candidates
    • AI VIVOselected other drugs as single and combinations from their top-ranked list and seeks partners with pharma companies and clinical trial investigators
     AI VIVO, the Cambridge based company combining systems pharmacology and artificial intelligence (AI) to accelerate drug discovery, has announced that it is seeking pharma and biotech collaboration partners to progress therapeutic candidates that have been identified by the Company as "top-ranked" for COVID-19
    Full story
  • CluePoints Covid-19 Support Benefits Over 200 Clinical Studies Directly Affected by the Pandemic

    May 7, 2020, 10:41 AM by Michael Croft
    KING OF PRUSSIA, PA, US - May 7, 2020 - CluePoints, the premier provider of Risk-Based Quality Management (RBQM) and Data Quality Oversight Software for clinical trials, today announced that its recently launched complimentary COVID-19 risk assessment package and Data Surveillance solution is being utilized in over 200 ongoing studies that are directly affected by Covid-19
    Full story
  • KCR’s Bryan Katz named in PM360’s ELITE 100

    May 7, 2020, 10:17 AM by Michael Croft
    BOSTON, MA - May 7, 2020 - KCR, the international clinical development solutions provider, announced today that its Chief Commercial Officer, Bryan Katz, was honored by healthcare marketing industry trade magazine PM360  as one of their 2020 ELITE 100 award winners
    Full story
  • Norway’s arctic university Tromsø installs MR Solutions’ high field, dry magnet, PET-MR imaging system

    May 7, 2020, 07:19 AM by Michael Croft
    GUILDFORD, UNITED KINGDOM - May 7, 2020 - For use in advanced medical research into inflammation, oncology and nephritis the 7T PET-MR imaging system from MR Solutions provides a combination of PET and MRI images either simultaneously or separately
    Full story
  • Covid-19 Volunteer Testing Network scaling up - delivering tests for GPs and care home workers

    May 7, 2020, 06:12 AM by Michael Croft
    OXFORD, UK - May 7, 2020 -
    • The Covid-19 Volunteer Testing Network is scaling up towards thousands of tests per day
    • 6 labs around the country are now live with 20 more in the pipeline
    • Local labs can deliver a fast-turnaround for their nearby GPs and care home workers
    • One lab in the network identified an outbreak in a community care provider with asymptomatic staff testing positive
    • Underscores the vital importance of regular screening of healthcare workers who might otherwise unknowingly be spreading the virus
    The Covid-19 Volunteer Testing Network has rapidly expanded testing capacity across the UK
    Full story
  • Halfpenny Technologies, an Accumen Company, Launches COVID-19 Test Capacity and Routing Network Across 870 U.S. Hospitals to Accelerate Diagnostic Testing

    May 6, 2020, 20:05 PM by Michael Croft
    PHOENIX, AZ - May 6, 2020 - Halfpenny Technologies, Inc., a wholly owned subsidiary of Accumen, Inc., today announced the launch of its COVID-19 Test Capacity and Routing Network (The “Network”)
    Full story
  • Widening Application Scope and COVID-19 Crisis, Set to Boost Market Growth of Immunoassays, Concludes Fact.MR

    May 6, 2020, 10:00 AM by Michael Croft
    DUBLIN 2, IRELAND - May 6, 2020 - As the number of chronic and infectious diseases compound, medical advancements have grown in equal proportion
    Full story
  • Lessons From Personalized Medicine Can Supercharge Coronavirus Testing

    May 6, 2020, 08:15 AM by Michael Croft

    Bio-IT World Contributed Commentary | Months into the Covid-19 pandemic, the United States remains dangerously behind on testing—and we know that technology from personalized medicine can help correct the chaos.

    Full story
  • Rho Experts Share Regulatory Best Practices on Product Development for the New Coronavirus

    May 5, 2020, 10:50 AM by Michael Croft
    RESEARCH TRIANGLE PARK, NC, UNITED STATES - May 5, 2020 -  WHAT:  Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, will outline new information from the Food and Drug Administration (FDA) on the new coronavirus (COVID-19) pandemic as it relates to ongoing and planned clinical research in an upcoming webinar, "Potential COVID-19 Products: Choosing the Right Path with FDA
    Full story
  • GRAIL Founder Returns To Illumina As CTO

    May 4, 2020, 16:45 PM by Michael Croft
    Bio-IT World | Illumina today announced the appointment of Alex Aravanis as Chief Technology Officer. Dr. Aravanis will be responsible for leading Illumina’s research and technology development functions and the innovation engine for next-generation sequencing platforms and applications, accelerating technology breakthroughs and translation to the clinic.
    Full story
  • SEKISUI XenoTech Expands Access to Top-Tier DDI Expertise & Consultancy

    May 4, 2020, 09:27 AM by Michael Croft
    KANSAS CITY, KS, UNITED STATES - May 4, 2020 - SEKISUI XenoTech is expanding opportunities for clients to work with top-tier consultants to evaluate drug-drug interaction potential of their drug candidate and bolster their preclinical data package for regulatory submission
    Full story
  • Follow the Money: New European Fund, All-Flash Storage, More

    May 4, 2020, 08:55 AM by Michael Croft
    Bio-IT World | New life sciences fund closes in Europe, big investments in VAST Data’s all flash storage, AI-written code, Lifebit’s CloudOS, Scopio Labs’s digital microscopy, microbiome tests and much more.
    Full story
  • Blockchain and its Impact on Epidemiology for COVID-19

    May 4, 2020, 08:15 AM by Michael Croft

    Bio-IT World Contributed Commentary | With the recent outbreak of COVID-19, epidemiologists around the world are researching and creating models on how to contain the disease. Blockchain technology exemplifies its use case within epidemiology by streamlining the process of distribution and providing trustworthy data.

    Full story
  • CHELSIO AND RYUSSI DEMONSTRATE END-TO-END iWARP RDMA BETWEEN WINDOWS 10 ENTERPRISE AND MoSMB SMB3 SERVER

    May 3, 2020, 05:33 AM by Michael Croft
    SUNNYVALE, CALIFORNIA - Feb 12, 2020 - Chelsio Communications, Inc., a leading provider of high performance (1Gb/10Gb/25Gb/40Gb/50Gb/100Gb) Ethernet Unified Wire adapters and ASICs for storage networking, virtualized enterprise datacenters, cloud service installations, and cluster computing environments, and Ryussi America, Inc, a Storage & Systems Product Development and Consulting company, today announced the results of the performance of Chelsio Terminator 6 (T6) iWARP RDMA adapters with Windows 10 Enterprise Client RDMA feature enabling high-speed access to the Ryussi MoSMB SMB3 server using SMB Direct
    Full story
  • «
  • 201
  • 202
  • 203
  • 204
  • 205 (current)
  • 206
  • 207
  • 208
  • 209
  • 210
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy